Lack of vision, loss of sight: Consequences of mandatory HTLV screening in corneal transplantation

Transplant Infectious Disease

Volumn 9, Issue 2, 2007, Pages 171-172

  Thomas, S ^a   Klapper, P E ^a   Mutton, K J ^a   Turner, A J ^a   Tullo, A B ^b   Zambrano, I ^b   Carley, F ^b   Taylor, A ^b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b Corneal Transplant Service Manchester Eye Bank ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ANTIBODY DETECTION; CORNEA TRANSPLANTATION; ENZYME IMMOBILIZATION; FALSE POSITIVE RESULT; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INCUBATION TIME; INFECTION RISK; LETTER; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; UNITED KINGDOM; VIRUS DETECTION; VIRUS DIAGNOSIS; VIRUS TRANSMISSION; WESTERN BLOTTING;

CORNEAL TRANSPLANTATION; DELTARETROVIRUS INFECTIONS; GREAT BRITAIN; HUMANS; PREVALENCE; SEROLOGIC TESTS; TISSUE DONORS;

EID: 34247583514     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2007.00225.x     Document Type: Letter

References (5)

1. Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type-I infection. Lancet 1999 353: 1961 1958.
2. Hollsberg P, Hafler DA. Seminars in medicine at the beth Israel hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 1993 328: 1173 1182.
3. Hall W, Ishak R, Zhu S, et al. Human T-lymphotropic virus type II (HTLV-II): epidemiology, molecular properties and clinical features of infection. J Acquir Immune Defic Syndr Hum Retrovirol 1996 13: S204 S214.
4. Pagliuca A, Pawson R, Mufti G. HTLV-I screening in Britain. Br Med J 1995 311: 1313 1314.
5. Ferreira OC Jr., Planelles V, Rosenblatt JD. Human T-cell leukemia viruses: epidemiology, biology, and pathogenesis. Blood Rev 1997 11: 91 104.